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Effects of Electrical Stimulation
of NAc Afferents on VP Neurons’
Tonic Firing
Martin Clark*
Department of Psychology, The University of Central Lancashire, Preston, United Kingdom
Afferents from the nucleus accumbens (NAc) are a major source of input into the ventral
pallidum (VP). Research reveals that these afferents are GABAergic, however, stimulation
of these afferents induces both excitatory and inhibitory responses within the VP. These
are likely to be partially mediated by enkephalin and substance P (SP), which are also
released by these afferents, and are known to modulate VP neurons. However, less
is known about the potentially differential effects stimulation of these afferents has on
subpopulations of neurons within the VP and the cellular mechanisms by which they
exert their effects. The current study aimed to research this further using brain slices
containing the VP, stimulation of the NAc afferents, and multi-electrode array (MEA)
recordings of their VP targets. Stimulation of the NAc afferents induced a pause in
the tonic firing in 58% of the neurons studied in the VP, while 42% were not affected.
Measures used to reveal the electrophysiological difference between these groups
found no significant differences in firing frequency, coefficient of variation, and spike
half-width. There were however significant differences in the pause duration between
neurons in the dorsal and ventral VP, with stimulation of NAc afferents producing a
significantly longer pause (0.48 ± 0.06 s) in tonic firing in dorsal VP neurons, compared
to neurons in the ventral VP (0.21 ± 0.09 s). Pauses in the tonic firing of VP neurons,
as a result of NAc afferent stimulation, were found to be largely mediated by GABAA
receptors, as the application of picrotoxin significantly reduced their duration. Opioid
agonists and antagonists were found to have no significant effects on the pause in tonic
activity induced by NAc afferent stimulation. However, NK-1 receptor antagonists caused
significant decreases in the pause duration, suggesting that SP may contribute to the
inhibitory effect of NAc afferent stimulation via activation of NK-1 receptors.
Keywords: ventral pallidum, multielectrode, reward, substance P, nucleus accumbens
INTRODUCTION
The ventral pallidum (VP) is a major output structure of the striatum and is innervated by
afferents from the nucleus accumbens (NAc). Many consider these afferents to be the main input
of the VP (Haber et al., 1985; Bolam et al., 1986). Activation of these afferents is involved in
pleasurable responses and sensitization to drugs of abuse (Smith and Berridge, 2005; Creed et al.,
2016). These afferents affect VP neurons through the release of associated neurotransmitters
and peptides. The NAc afferents of the VP release GABA (Walaas and Fonnum, 1979;
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Mogenson et al., 1983; Yang and Mogenson, 1985; Churchill
et al., 1990; Reiner and Anderson, 1990; Zaborszky and Cullinan,
1992; Churchill and Kalivas, 1994; Kitamura et al., 2001).
However, research has shown that stimulation of these afferents
produces both inhibition and excitation of VP neurons (Chrobak
and Napier, 1993). Enkephalin and substance P (SP), as well as
GABA, is probably involved in these responses as both are known
to be released by these afferents (Haber et al., 1985; Napier et al.,
1995; Lu et al., 1997). Enkephalin, has been shown to contribute
(along with GABA) to the inhibition of VP neurons seen in
response to stimulation of NAc afferents (Napier et al., 1992), and
SP is known to produce excitatory responses in the VP (Napier
et al., 1995), therefore SP is a likely candidate to be involved in the
excitation of VP neurons as a result of NAc afferent stimulation.
Questions remain as to what neurons the afferent connections
of the NAc target in the VP. Research suggests they may directly
target cholinergic interneurons in the VP (Grove et al., 1986;
Zaborszky et al., 1986; Zaborszky and Cullinan, 1992), although
recent research by Root et al. (2015) suggest NAc afferents
also directly innervate GABAergic neurons of the VP. Further
research needs to elucidate how stimulation of these afferents
modulates the VP neurons they innervate. The question also
remains as to what receptors are involved in the modulatory
effects of NAc inputs to the VP. The research suggests a strong
involvement of GABAA receptors (Chrobak and Napier, 1993).
However NK-1 receptors (Maeno et al., 1993; Chen et al., 2001),
δ-opioid receptors, and µ-opioid receptors (Lahti et al., 1989;
Mitrovic and Napier, 1995) are also known to be present in the
VP and neurons in the VP are responsive to their activation
(Chrobak and Napier, 1993; Napier et al., 1995). It can be
hypothesized that SP and enkephalin, released by NAc afferents
to the VP target these receptors and modulate the effects of
GABA on these neurons.
It is important to understand further how activation of
NAc inputs into the VP, and the neuromodulators released,
impact on VP neurons. Unraveling the potentially divergent,
modulatory effects these connections have on the interneurons
and projection neurons of the VP may reveal important
information relating to drugs of abuse, affective disorders, and
aspects of reward learning, as these areas, and their connections,
are heavily involved in these processes.
MATERIALS AND METHODS
Animals
Extracellular in vitro recordings were obtained from C57 mice
that were bred and housed in the Biological services facility at the
University of Sheffield.
Slice Preparation
Mice of both sexes aged between 28 and 42 days were culled by
cervical dislocation with death being confirmed by decapitation
in line with the 1986 Animals (Scientific procedures) Act, and
with approval from the UKHomeOffice. Following decapitation,
the brain was rapidly removed from the skull and parasagittal
slices of 400 µm obtained using a vibrating microtome (as
per Beurrier et al., 2006; Cambden instruments) immersed in
ice-cold (5◦C), oxygenated (saturated 95% O2 and 5% CO2)
sucrose cutting solution. This solution was prepared fresh daily
and contained (inmM): Sucrose (184), KCl (2.5), NaH2PO4 (1.2),
NaHCO3 (30), HEPES (20), Glucose (25), sodium ascorbate (5),
Thiourea (2), sodium pyruvate (3), MgSO4 (10), CaCl2 (0.5).
Once cut, slices were transferred to a recovery chamber
maintained at 26◦C, containing a Tris recovery solution, which
was continuously aerated with a carbogen mixture of 95%
O2 and 5% CO2 gas. As with the sucrose cutting solution,
the Tris recovery solution was freshly prepared daily and
contained (in mM): Tris HCl (76), Tris base (19.5), KCl
(2.5), NaH2PO4 (1.2), NaHCO3 (30), HEPES (20), Glucose
(25), sodium ascorbate (5), Thiourea (2), sodium pyruvate (3),
MgSO4 (10), CaCl2 (0.5) The slices incubated in this chamber
for 30 min, before being transferred to another chamber for
storage. This storage chamber was also maintained at 26◦C and
contained standard aCSF, continuously aerated with a carbogen
mixture of 95% O2 and 5% CO2 gas. The standard aCSF was
also made up daily and contained (in mM): NaCl (124), KCl
(3), NaH2PO4 (1.2), NaHCO3 (26), Glucose (15), MgSO4 (2),
CaCl2 (2). Slices were then left for a minimum of 60 min
to equilibrate and recover before being transferred into the
pMEA (perforated Multi-Electrode Array) recording chamber
for electrophysiological recordings.
pMEA Electrophysiological Recordings
Neural network activity was monitored and recorded using
a pMEA (Multi-Channel Systems, Reutlingen, Germany).
The pMEA contained 60 embedded electrodes, which were
constructed of titanium nitrite. Each electrode has a diameter
of 30 µm and they are spaced at 200 µm. Selected channels
of electrical activity were recorded and digitized at a sampling
rate of 10 kHz using a MEA1060-Up-BC amplifier and
MC Rack software (version: 4.6.2, Multi-Channel Systems,
Reutlingen, Germany).
Once in the recording chamber of the pMEA slices were
moved into position over the electrodes of the pMEA using a
fine-tipped artists brush. The bottom flow was then switched on
to produce suction and fix the slice into position. Using a pair
of fine-tipped tweezers, a mesh harp was then placed on top of
the slice and a top flow applied as quickly as possible. This was
done to ensure the health and viability of the slices. Both the
top and bottom flow (perfusion) were of continuously aerated
aCSF containing (in mM): NaCl (124), KCl (3), NaH2PO4 (1.2),
NaHCO3 (26), Glucose (15), MgSO4 (2), CaCl2 (2). The bottom
flow rate was maintained at 0.65–1 ml/min and the top flow was
maintained at 3–5ml/min. The activity wasmonitored for at least
1 h before recordings commenced.
Slice Visualization
To identify the correct area of the slice for the recording of VP
neurons and subsequent stimulation of the NAc, the pMEA was
placed in the amplifier, then using an Olympus BX51microscope
with a 4× lens, visualized via a Tucson digital microscope
camera, which sent a live feed to a Viglen computer (4 gb of
memory and an i5 processor) running IS capture software.
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The VP was considered as any area ventral to the caudal
anterior commissure and before the caudal edge of the rostral
anterior commissure as it subdivides the striatum into its
dorsal and ventral extents. The NAc was considered as any
area directly ventral to the rostral extent of the anterior
commissure and the left of the identified VP region. For
stimulation experiments identification of the dorsal and ventral
extents of the VP was necessary. The dorsal VP was defined
as any electrode, located within the VP, which was within
500 µm of the caudal anterior commissure. The ventral VP
was defined as any region, located in the identified VP,
over 600 µm away from the ventral edge of the caudal
anterior commissure.
Stimulation Methods and Protocols
Stimulation was performed using an STG 1002 (Multi-Channel
Systems, Reutlingen, Germany), which was programmable via
MC_stimulus software (version 2.1.5, Multi-Channel Systems,
Reutlingen, Germany). Stimulation was delivered via the internal
electrodes of the multi-electrode array (MEA) chip, the electrode
to be used for stimulation was selected based upon the location
of the slice in the MEA chip chamber, which was observed via
the video stream from the camera mounted on the optic of the
microscope. Electrodes were always chosen for stimulation that
was at least 400 µm away from the rostral edge of the identified
VP. Once the correct area, and the corresponding electrodes
in this area, were identified, MC_select software (version 1.3.0,
Multi-Channel Systems, Reutlingen, Germany), which allows
you to allocate the embedded electrodes as stimulating channels,
was used to administer a biphasic stimulation. Two electrodes
adjacent to one another in the MEA were always selected for the
delivery of stimulation. The stimulation was always bipolar, with
a negative followed by positive polarity, in line with multichannel
systems suggestions (Wagenaar et al., 2004, 2005). The voltage
of stimulation never exceeded ±3,000 mV and lasted for a
duration of:
• one stimulation of 200 µs duration followed by a 10-s gap,
before the next trial.
• HFS (high-frequency stimulation) which was at 100 Hz:
five stimulations of 300 µs duration with 9,700 µs gap
between each, giving a total stimulation time of 50 ms. Each
trial was 10 s apart.
Pharmacology
All drugs were obtained from either Tocris Biosciences (UK) or
Sigma Aldrich and were bath applied into the header reservoir
feeding the top perfusion flow of the pMEA at the following
concentrations:
1. Picrotoxin: (picrotoxin) 20 µM.
2. N-Acetyl-L-tryptophan 3, 5-bis(trifluoromethyl)benzyl ester:
(L732,138) 20 µm.
3. (5α)-4, 5-Epoxy-3, 14-dihydro-17-(2-propenyl)morphinan-6-
one hydrochloride: (Naloxone) 20 µM.
4. [D-Ala2, NMe-Phe4, Gly-ol5]-enkephalin: (DAMGO)
20 µM.
Data Analysis
Data was acquired using Mc_rack software (version: 4.6.2)
and a MEA1060-Up-BC amplifier (Multi-Channel Systems,
Reutlingen, Germany). Files (.mcd) were converted to .ced files
using multichannel data manager software (version: 1.9.7, Multi-
Channel Systems, Reutlingen, Germany) for off-line analysis
using Spike 2 software (C.E.D). Please see Clark and Bracci
(2018) for further detail on how this software was used for offline
spike sorting.
See figure legends for information on result expression. All
error bars are expressed as SEM.
Pause duration was calculated as the amount of time taken for
the neuron to return to 90% of the pre-stimulation firing rate.
If this occurred in <100 ms these neurons were considered as
non-pauses. If the pause duration was >100 ms these neurons
were considered pauses. This was done to ensure the HFS,
which lasted for 50 ms, was not falsely accepted as a pause
in firing.
To assess differences in a neuron’s firing frequency in
different pharmacological treatments. I measured consecutive
inter-spike intervals (ISIs) at the end of the stimulation protocol
and during the final 60 s of each pharmacological condition.
Average ISIs for relevant conditions were then compared using
a Student’s t-test. A statistically significant difference was
considered to be present if P < 0.05. If treatment caused a
significant increase in ISI, I refer to this observation in the results
as a significant decrease in firing frequency and an inhibitory
effect of the treatment. If treatment caused a significant decrease
in ISI, I refer to this observation as a significant increase in
firing frequency and an excitatory effect of the treatment. The
coefficient of variation and spike half-width was also calculated
in different pharmacological treatments during the final 60 s
of each pharmacological condition. The coefficient of variation
(CoV) was calculated as a measure of spike train variability in
different pharmacological conditions and as a potential way of
identifying different neuronal types in the VP. It was calculated
as the standard deviation (ISI)/Mean ISI. The threshold for
spike detection was considered to be reached when the recorded
voltage departed from baseline (0 mV in AC recording mode) by
more than the standard deviation of the voltage recorded for that
channel during an apparently quiescent period (of at least 3 s).
Spikes consisted of a biphasic negative-positive waveform. Spike
amplitude was defined as the difference between the negative
voltage peak and the spike threshold level defined above. Spike
half-width was defined as the time the value of the recorded
voltage (measured from the threshold level) remained more
negative than half of the spike amplitude (Pettersen and Einevoll,
2008; Clark and Bracci, 2018).
RESULTS
Stimulation of the NAc Inhibits Tonic Firing
in Some VP Neurons
To explore the effect that NAc afferents have on VP neurons, I
stimulated the NAc every 10 s and measured the changes in tonic
firing activity within the dorsal and ventral extents of the VP.
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From 13 experiments, 52 neurons were identified for analysis
as they had a stable tonic firing rate after 1 h of slice
accommodation in the multielectrode array. Stimulation of the
NAc induced a pause (referred to as responders) in firing in
30/52 of these neurons (Figures 1A,B), with 53% being located
in dorsal extents of the VP and 47% being located in ventral
extents of the VP (Figure 1E). The 22/52 were not affected
by NAc stimulation (referred to as non-responders) with 41%
being located in the dorsal extent of the VP and 59% being
located in the ventral extent of the VP (Figure 1E). Pause
duration was 0.29 ± 0.03 s for those classed as responders
(Figure 1C).
To ascertain if pauses were elicited in different types
of neurons within the VP, firing frequency, coefficient, and
variation and spike half-widths were calculated for responders
and non-responders. There was no significant (P > 0.05)
difference in the average baseline firing frequency rates between
responders 18.16± 3.16 Hz and non-responders 15.27± 2.83 Hz
(Figure 1F). There was no significant (P > 0.05) difference in
the coefficient of variation between responders 27.07 ± 9.61 and
non-responders 19.27 ± 2.51 (Figure 1G). Finally, there was
no significant difference in spike half-width (ms) between
responders 0.32 ± 0.02 ms and non-responders 0.35 ± 0.03 ms
(Figure 1D).
I conclude that a significant population of neurons in the VP
is directly inhibited by afferents from the NAc and that these
neurons are evenly dispersed between the dorsal and ventral
extents of the VP. There is however a significant population that
was not directly inhibited by NAc stimulation.
NAc Stimulation Induces Pauses of
Different Durations Dorsally Compared to
Ventrally in the VP
To ascertain if there were any regional differences in pause
duration between dorsal and ventral extents of the VP, the pause
duration of neurons identified as in dorsal portions of the VP
were compared to neurons in ventral portions of the VP.
From 10 experiments I identified 17 neurons in the VP for
analysis as they responded to NAc stimulation. The 7/17 of these
were classified as being located dorsally (Figure 2A) in the VP
and 10/17 of these were classified as located ventrally within the
VP (Figure 2B). Ventrally located neurons paused for an average
duration of 0.21 ± 0.09 s while dorsally located neurons paused
for an average duration of 0.48 ± 0.06 s. This was significantly
different (P < 0.05; Figure 2C).
To ascertain if these differences represented different
populations of neurons in the dorsal VP compared to the ventral
VP I compared them based on the baseline firing frequency,
coefficient of variation, and spike half-width profiles. There was
no significant difference in the average baseline firing frequency
rates between those neurons located dorsally within the VP
17.13 ± 4.06 Hz and those located ventrally within the VP
16.13± 2.08 Hz (Figure 2D). There was no significant difference
in the coefficient of variation between those neurons located
dorsally 24.85 ± 11.06 and those located ventrally 22.05 ± 8.53
(Figure 2E). Finally, there was no significant difference in spike
half-width (ms) between those located dorsally 0.29 ± 0.04 ms
and those located ventrally 0.36 ± 0.05 ms (Figure 2F).
I tentatively conclude that inputs arriving from the NAc to
dorsal regions in the VP have a greater inhibitory effect on the
VP’s tonic firing than those inputs from theNAc arriving inmore
ventral regions of the VP, but this does not appear to be related
to the type of neuron they innervate within the VP.
Picrotoxin Abolishes VP Neurons Inhibition
by NAc Stimulation
Research suggests that afferent projections from the NAc
innervating the VP are GABAergic. This should mean that the
application of GABAA antagonists should largely ameliorate the
inhibition in tonic firing seen in response to NAc stimulation. To
explore the role of GABA in the inhibition of VP neurons, the
GABAA antagonist picrotoxin was applied during stimulation of
the NAc.
From 12 experiments 26 neurons in the VP were identified
for analysis that paused in response to NAc stimulation
(Figures 3A,B). The average pause duration for these 26 neurons
was 0.34 ± 0.04 s. For these 26 neurons, after the application of
picrotoxin, the pause duration was 0.06 ± 0.01 s (Figure 3F). As
the pause duration measured after the application of picrotoxin
was significantly (P < 0.001) shorter than before the application
of picrotoxin (Figure 3E), I can conclude that the inhibition
induced in tonically active VP neurons by NAc stimulation is
largely a result of GABA release and subsequent activation of
GABAA receptors.
To investigate if the application of picrotoxin had any effect
on electrophysiological characteristics of the VP neurons I
measured baseline firing frequency rates, coefficient of variation,
and spike half-width for the VP neurons pre and post-application
of picrotoxin. The firing frequency (Hz) rates were not
significantly (P> 0.05) different for any (pauses and non-pauses)
VP neurons studied in the presence of picrotoxin 21.52± 0.49Hz
compared to control conditions 18.59 ± 1.97 Hz (Figure 3C).
The coefficient of variation was also not significantly (P > 0.05)
different for any (pauses and non-pauses) VP neurons studied
in the presence of picrotoxin 29.75 ± 10.42 compared to control
conditions 35.39 ± 4.34 (Figure 3D). Spike half-width (ms) was
also not significantly (P > 0.05) different for any (pauses and
non-pauses) VP neurons studied in the presence of picrotoxin
0.31 ± 0.01 ms compared to control conditions 0.32 ± 0.04 ms
(Figure 3E).
I can therefore conclude that application of picrotoxin has
no significant (P > 0.05) effects on the electrophysiological
characteristics of the VP neurons but abolishes the inhibitory
influence stimulation of NAc neurons has on VP neurons.
Inhibition of VP Neurons by NAc
Stimulation Is Not Affected by Opioid
Antagonists
To investigate the role of opioids and opioid receptors in the
inhibition of VP neurons by NAc stimulation, opioid agonists
(DAMGO), and the non-specific opioid receptor antagonist,
naloxone, were applied during stimulation of the NAc.
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FIGURE 1 | Stimulation ofthe nucleus accumbens (NAc) results in inhibition of tonic firing in some ventral pallidum (VP) neurons. All experiments represented in this
figure used the second stimulation protocol (100 Hz) identified in the “Materials and Methods,” section. (A) A typical example of a raw data trace from a neuron in the
VP with a pause (responder) in tonic activity after stimulation of the NAc. (B) A typical example raster plot (above) and peri-stimulus time histogram (PTSH, below, in
bins of 10 ms) of tonic firing activity in a VP neuron 0.5 s pre-stimulation and 0.5 s post-stimulation of the NAc. The raster plot exemplifies one neuron response
during 400 applications of stimulation. (C) Bar chart representing average pause duration for those neurons that were responders to NAc stimulation. (D) Bar chart
representing the non-significant difference in spike half-width (ms) for neurons that responded to NAc stimulation (green) and those that were non-responders
(yellow). (E) Pie charts representing the proportion of neurons identified in the VP for analysis that responded to NAc stimulation, and the proportions that were
located ventrally vs. dorsally within the VP. (F) Bar chart representing non-significant differences in baseline firing frequency rates for neurons that responded to NAc
stimulation (green) and those that were non-responders (yellow). (G) Bar chart representing the non-significant difference in baseline coefficient of variation for those
neurons that responded to NAc stimulation (green) and those that were non-responders (yellow).
From five experiments 11 neurons were identified for analysis
that paused in response to NAc stimulation (Figure 4A).
In control conditions, the average pause duration for these
11 neurons was 0.32 ± 0.06 s. For these 11 neurons after
the application of naloxone, the average pause duration was
0.31 ± 0.07 s. The pause duration after the application of
naloxone was not significantly (P > 0.05) different from the
pause duration before the application of naloxone (Figure 4C).
However, the pause duration (consistent with Figure 3E) was
significantly (P < 0.05) reduced, compared to control conditions
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FIGURE 2 | NAc stimulation induces a longer pause duration in dorsal VP neurons than ventral. All experiments presented in this figure used the first stimulation
protocol (one stimulation of 200 µs duration followed by a 10-s gap) identified in the “Materials and Methods” section. (A) A typical example raster plot of tonic firing
activity in a VP neuron 0.5 s pre-stimulation and 1.0 s post-stimulation of the NAc. The raster plot exemplifies one neuron’s response in the dorsal VP during
150 applications of stimulation. (B) A typical example raster plot of tonic firing activity in a VP neuron 0.5 s pre-stimulation and 1.0 s post-stimulation of the NAc. The
raster plot exemplifies one neuron response in the ventral VP during 150 applications of stimulation. (C) Bar chart representing significant differences (*P < 0.05) in
pause duration between those neurons studied in the dorsal VP compared to those in the ventral VP. (D) Firing frequency (Hz) for neurons that paused in response to
NAc stimulation in the dorsal VP compared to those in the ventral VP. (E) Coefficient of variation for neurons that paused in response to NAc stimulation in the dorsal
VP and those in the ventral VP. (F) Spike half-width (ms) for neurons that paused in response to NAc stimulation in the dorsal VP compared to those in the ventral VP.
and naloxone, after the application of picrotoxin 0.04 ± 0.07 s
(Figure 4C). I, therefore, conclude that opioid receptors do not
modulate the pause in firing seen in VP neurons, induced by
stimulation of the NAc afferents.
To investigate if the application of naloxone had any effect
on electrophysiological characteristics of the VP neurons, I
measured baseline firing frequency rates and coefficient of
variation for the VP neurons (Figures 4E,F). The firing frequency
(Hz) rates were not significantly (P > 0.05) different for the VP
neurons studied in the presence of naloxone 19.35 ± 2.91 Hz
compared to control conditions 18.00± 3.02Hz and the presence
of picrotoxin 19.82 ± 3.75 Hz. The coefficient of variation was
also not significantly (P > 0.05) different for the VP neurons
studied in the presence of naloxone 40.72 ± 16.79 compared to
control conditions 27.07 ± 9.52 and picrotoxin 51.32 ± 22.93.
To verify that opioids did not play a role in modulation of
the pause duration induced by NAc stimulation, I also applied
DAMGO during stimulation of the NAc.
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FIGURE 3 | Picrotoxin substantially disinhibits VP neurons inhibited by NAc stimulation. All experiments presented in this figure used the first stimulation protocol
(one stimulation of 200 µs duration followed by a 10-s gap) identified in the “Materials and Methods” section. (A) A typical example of a raw data trace from a
neuron in the VP with a pause in tonic activity after stimulation of the NAc and a raw trace from the same neuron after the application of picrotoxin with no pause in
tonic activity. (B) A typical example raster plot of tonic firing activity in a VP neuron from 0.5 s pre-stimulation to 0.5 s post-stimulation of the NAc. The raster plot
exemplifies one neuron response during 600 applications of stimulation in control conditions and 600 stimulations after the application of picrotoxin. To the right of
the raster plot are two representative traces, the light green being before the application of picrotoxin and the dark green being after the application of picrotoxin.
(C) Bar chart representing the no-significant difference in baseline firing frequency (Hz) for neurons that pause and those that did not pause in response to NAc
stimulation, in control conditions and in the presence of picrotoxin. (D) Bar chart representing no-significant differences in baseline coefficient of variation for neurons
that pause and those that did not pause in response to NAc stimulation, in control conditions, and in the presence of picrotoxin. (E) Bar chart representing
no-significant differences in spike half-width for neurons that pause and those that did not pause in response to NAc stimulation, in control conditions, and in the
presence of picrotoxin. (F) Bar chart representing significant differences (***P < 0.001) in pause duration for those neurons that paused in response to NAc
stimulation (green) compared to the same neurons in the presence of picrotoxin, and compared to those neurons that did not pause in response to stimulation
(yellow) in control conditions and in the presence of picrotoxin.
From three experiments five neurons were identified for
analysis that paused in response to NAc stimulation (Figure 4B).
In control conditions, the average pause duration for these
five neurons was 0.40 ± 0.11 s. For these five neurons
after the application of DAMGO, the average pause duration
was 0.31 ± 0.08 s (Figure 4D). The pause duration after
the application of DAMGO was not significantly (P > 0.05)
different from the pause duration before the application
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FIGURE 4 | Inhibition of VP neurons by NAc stimulation is not affected by opioid agonists. All experiments presented in this figure used the first stimulation protocol
(one stimulation of 200 µs duration followed by a 10-s gap) identified in the “Materials and Methods” section. (A) A typical example of a raster plot of tonic firing
activity in a VP neuron (from −0.5 s to 0.5 s post-stimulation of the NAc). The raster plot shows a neuron’s response during 800 applications of stimulation in control
conditions, 800 stimulations after the application of naloxone, and 800 stimulations after the application of picrotoxin. (B) A typical example raster plot of tonic firing
activity in a VP neuron 0.5 s pre-stimulation and 0.5 s post-stimulation of the NAc. The raster plot exemplifies one neuron’s response during 800 applications of
stimulation in control conditions, 800 stimulations after the application of DAMGO, and 800 stimulations after the application of picrotoxin. (C) Bar chart representing
significant differences (**P < 0.01) in pause duration for neurons in control conditions, the presence of naloxone and the presence of picrotoxin. (D) Bar chart
representing significant differences (*P < 0.01 and *P < 0.05) in pause duration for neurons in control conditions, the presence of DAMGO, and the presence of
picrotoxin. (E) Bar chart representing non-significant (P > 0.05) differences in the average firing frequencies for neurons in control conditions, in the presence of
naloxone and in the presence of picrotoxin. (F) Bar chart representing non-significant (P > 0.05) differences in the coefficient of variation for neurons in control
conditions, in the presence of naloxone and in the presence of picrotoxin. (G) Bar chart representing non-significant (P > 0.05) differences in the average firing
frequencies for neurons in control conditions, in the presence of DAMGO and in the presence of picrotoxin. (H) Bar chart representing non-significant (P > 0.05)
differences in the coefficient of variation for neurons in control conditions, in the presence of DAMGO, and in the presence of picrotoxin.
of DAMGO. The pause duration was, however significantly
(P < 0.05) reduced, compared to control conditions and
DAMGO, after the application of picrotoxin 0.04 ± 0.07 s
(Figure 4D).
To check if DAMGO affected the electrophysiological
characteristics of VP neurons I measured baseline firing
frequency rates and coefficient of variation for the VP neurons
(Figures 4G,H). The firing frequency (Hz) rates were not
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 November 2020 | Volume 14 | Article 599920
Clark NAc Afferents Effect VP neurons
significantly (P > 0.05) different for the VP neurons studied in
the presence of DAMGO 14.01 ± 4.26 Hz compared to control
conditions 15.89 ± 3.79 Hz and picrotoxin 11.82 ± 1.76 Hz.
The coefficient of variation was also not significantly (P > 0.05)
different for the VP neurons studied in the presence of DAMGO
60.89 ± 12.69 compared to control conditions 39.95 ± 8.63 and
picrotoxin 53.42 ± 10.21.
I, therefore, conclude that opioid receptors appear to have no
modulatory effect on the pause in firing seen in VP neurons,
induced by stimulation of the NAc afferents.
NK-1 Receptors Modulate the Effect of
NAc Stimulation on VP Tonic Firing
To investigate the effects of SP receptors on the inhibition of
VP neurons by NAc stimulation, I applied L732,138, which is an
NK-1 receptor antagonist, during stimulation of the NAc.
From three experiments eight neurons were identified
for analysis that paused in response to NAc stimulation
(Figure 5A). In control conditions, the average pause
duration for these neurons was 0.39 ± 0.06 s, for these
eight neurons, after the application of L732,138 the average
pause duration was 0.26 ± 0.06 s. The pause duration, after
the application of L732,138, was significantly (P < 0.05)
reduced compared to the pause duration in control
conditions (Figure 5B). The pause duration was further
significantly (P < 0.001) reduced, compared to control
conditions, with the application of picrotoxin 0.07 ± 0.02 s
(Figure 5B).
To investigate if the application of L732,138 had any effect on
electrophysiological characteristics of the VP neurons Imeasured
baseline firing frequency rates and coefficient of variation for
the VP neurons. The firing frequency (Hz) rates were not
significantly (P > 0.05) different for the VP neurons studied in
the presence of L732,138 20.15 ± 3.67 Hz compared to control
conditions 20.75 ± 1.69 Hz and the presence of picrotoxin
22.77± 3.15 Hz (Figure 5C). The coefficient of variation was also
not significantly (P > 0.05) different for the VP neurons studied
in the presence of L732,138 13.55 ± 1.57 compared to control
conditions 12.90 ± 1.53 and picrotoxin 13.93 ± 2.9 (Figure 5D).
I, therefore, conclude that SP contributes to the inhibition
seen in VP neurons in response to NAc stimulation by activation
of NK-1 receptors.
DISCUSSION
The present research concludes that the MEA setup can be
used successfully to study the connections between the striatum
and its output nuclei. In this case, specifically between the
NAc and the VP. I provide support, using a novel method,
for previous research (Wang et al., 2014) suggesting that the
NAc afferents of the VP have an inhibitory impact on VP
neurons, as activation of the NAc afferents produced inhibition
in tonic firing for several VP neurons. The current study
also identified several, tonically active neurons, across all VP
territories that were not inhibited by activation of afferents
from the NAc. I tentatively conclude that activation of NAc
afferents does not inhibit all the neurons in the VP and
this may relate to a type of neuron not directly targeted by
NAc afferents.
These findings also revealed no distinct difference in any of
our electrophysiological measures (firing frequency, coefficient
of variation, and spike half-width) for those neurons that
responded to the activation of NAc afferents and those that were
non-responders. The lack of electrophysiological differences
between those neurons that responded to NAc stimulation and
those that were non-responders may be masked by within-
group variability. Research suggests NAc afferents target multiple
different types of neurons in the VP, including GABAergic and
cholinergic (Grove et al., 1986; Zaborszky, 1989; Root et al.,
2015), therefore the electrophysiological measures used may be
distorted by this within-group variability. Future research could
use BAC transgenic animals with a GFP (green fluorescent
protein) promoter for fluorescence in cholinergic neurons, to
identify these in the slice.
I conclude that SP, released from NAc afferents into the
VP, contributes to the pause duration produced as a result of
NAc stimulation through activation of NK-1 receptors. This
is unexpected as blocking a known excitatory influence was
expected to prolong the pause duration.
Difference in Pause Duration Dorsal to
Ventral Within the VP
The current study has also shown that the inhibitory effects
of NAc inputs of the VP are evenly dispersed, with a similar
number of neurons being inhibited in dorsal regions of the VP
as were inhibited in more ventral regions of the VP. This even
distribution across the VP is also the case for the neurons that
were not inhibited by the activation of NAc afferents. On the
other hand, there was a significant difference in the duration of
the inhibition between neurons in dorsal and ventral territories of
the VP, with the dorsal regions exhibiting a significantly longer
pause in firing in response to activation of the NAc afferents
than did ventrally located neurons in the VP. This could relate
to the differences in the functional roles of these territories or
code an imbalance in projections from dorsal regions and from
ventral regions to their prospective targets. Root et al. (2015)
suggest that the connections between the nucleus accumbens
shell (NAcS) and ventromedial VP are involved in the initiation
of drug-seeking (identifying the conditions for drug use) while
nucleus accumbens core (NAcC) to dorsolateral VP is involved
in the continuation of drug-seeking (addiction). I, therefore,
speculate that drugs of abuse alter this imbalance in pause
duration between ventral and dorsal VP neurons resulting in a
shift from initiation to a continuation of drug-seeking. Further
research would be pertinent in slices from drug sensitized
animals, to investigate if the difference in pause duration between
dorsal and ventral VP territories, is altered by sensitization to
drugs of abuse.
The fact that brain slice preparations are likely to only
preserve a small proportion of the connections between brain
regions, could account for the differences in pause duration
dorsally to ventrally within the VP. Caution should be taken as
these results could be due to more afferents to dorsal VP being
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FIGURE 5 | Inhibition of VP neurons by NAc stimulation is modulated by NK-1 receptors. All experiments represented in this figure used the second stimulation
protocol (100 Hz) identified in the “Materials and Methods” section. (A) A typical example raster plot of tonic firing activity in a VP neuron from 0.5 s to 1.0 s
post-stimulation of the NAc. The raster plot exemplifies one neuron response during 200 applications of stimulation in control conditions, 200 stimulations after the
application of L732,138, and 200 stimulations after the application of picrotoxin. (B) Bar chart representing significant (*P < 0.05, ***P < 0.001) differences in the
average pause duration (ms) for neurons in the VP after NAc stimulation. Each bar represents the average pause duration in different pharmacological conditions: in
control conditions, in the presence of L732,138, and in the presence of picrotoxin. (C) Bar chart representing non-significant (P > 0.05) differences in the average
firing frequencies for neurons in control conditions, in the presence of L732,138 and in the presence of picrotoxin. (D) Bar chart representing non-significant
(P > 0.05) difference in the coefficient of variation for neurons in control conditions, in the presence of L732,138 and in the presence of picrotoxin.
intact in our brain slice preparations compared to the number of
afferents to ventral VP.
Neurotransmitters and Neuropeptides
Modulating Pause Duration
As for the pharmacology of these inhibitory effects on VP
neurons, I found that the GABAA antagonists (picrotoxin)
largely removed the pause in tonic firing, seen in some
VP neurons, induced by activation of the NAc afferents. I
conclude that the inhibitory effect of NAc afferent activation
on a subset of VP neurons is predominantly mediated by
the release of GABA and the activation of GABAA receptors
on target VP neurons, thus resulting in a pause in tonic
activity. This makes sense in the light of the dominant
labeling/expression of GABAA as opposed to GABAB in the VP
(Zilles et al., 1991; Henderson, 1995). This also supports the
immunohistochemical research (Churchill and Kalivas, 1994)
and the previous electrophysiological work of Chrobak and
Napier (1993), which suggests GABA antagonists disinhibit VP
neurons. Although the pause duration we found was consistent
with the published literature of evoked GABA potentials in the
pallidal regions at room temperature 25◦C (Ogura and Kita,
2000). Future research needs to confirm these likely GABA
currents. This can be done by using patch-clamp techniques
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to record in the voltage-clamp mode, to confirm that a GABA
current was indeed activated in VP neurons by stimulation of
the NAc.
Multiple different subtypes of GABAA receptors are known
to be expressed in the VP and its dorsal division the GP (globus
pallidus), including the α1β2γ2 receptor subtype (Duncan
et al., 1995) and the α2β2γ2 subtype (Goetz et al., 2007).
Immunocytochemistry studies (Pirker et al., 2000) show that
many of the subunit variants of GABAA receptors (α1–α6,
β1–β3, γ1–γ3 and δ) are expressed in the VP, suggesting a large
variety of GABAa receptor types in the region. While the current
study does not elucidate their relative contributions to the pause
evoked by NAc stimulation, focused targeting of these specific
subtypes would prove a fruitful line of inquiry for future research
of the VP.
Recent research suggests both direct and indirect pathway
MSN’s project into the VP (Creed et al., 2016; Kupchik and
Kalivas, 2016). These release enkephalin (indirect) and SP
(direct) and therefore these neuropeptides would seem likely
candidates to contribute to the pause in tonic firing induced
by activation of the NAc afferents. The current study found
there to be no effect of opioid antagonists on the pause
induced by stimulation of afferents from the NAc. I conclude
that, although enkephalin may be released by these neurons,
it has no apparent modulatory effect on the neurons directly
inhibited by activation of these afferents. Opioid antagonists
were also not found to have any significant effect on the
firing frequency and coefficient of variation for those neurons
that paused. This is contrary to much of the research, which
suggests enkephalin modulates VP neurons (Chrobak and
Napier, 1993; Napier and Mitrovic, 1999). Indeed, caution is
needed in the interpretation of our results. The stimulation
technique used in our studies on opioids is known to favor
the release of GABA/glutamate and not neuropeptides, such as
enkephalin. Therefore, the lack of modulatory effect seen in
response to opioid antagonists could simply be an artifact of
the stimulation protocol not resulting in neuropeptide release.
However, Mitrovic and Napier (1995) have shown that a
significant proportion of VP neurons do not respond to any
opioid agonist. It could therefore be that those neurons directly
inhibited by NAc afferents are those that are not modulated
by enkephalin.
The VP is heavily innervated by multiple other regions,
supplying dopaminergic, serotonergic, glutamatergic, and
cholinergic input (Root et al., 2015). It is therefore worth
considering the role that other inputs into the VP play in
modulating the activity of neurons in the region. There are
well known dopaminergic inputs from the VTA (ventral
tegmental area) with research showing that dopamine can
induce dichotomous (excitatory and inhibitory) responses in
different populations of VP neurons (Clark and Bracci, 2018).
There are also serotonergic inputs from the Dorsal Raphe Nuclei
(DRN), with research showing that serotonin, like dopamine,
can induce dichotomous responses in VP neurons (Bengtson
et al., 2004). Certainly, the contribution of these other inputs,
and the interplay between these and those from the NAc, would
be an excellent avenue for future research, revealing a likely
complex interplay and effect on the pause induced by NAc
stimulation in the VP.
Methodological Issues With Stimulation
Protocols
The stimulation protocol used for the experiments involving
opioid antagonists was probably biased against the release
of neuropeptides, as it involved the use of a low-frequency
stimulation, which is known to favor the release of GABA and
glutamate and not neuropeptides, such as enkephalin (Purves,
2001). Further to this I also used the non-selective opioid
antagonist Naloxone. This meant that other opioid receptors
(kappa and delta), which are known to be present in the VP
(Mitrovic and Napier, 1995; Olive et al., 1997), would have
been inhibited, thus potentially masking the effects of enkephalin
by also modulating the effects of dynorphin. Future research
should include high-frequency stimulation protocols, such as
that used in our experiments withNK-1 antagonists, and selective
enkephalin antagonists to avoid these issues.
Substance P Modulation of Pause Duration
The current study suggested, unexpectedly, that SP contributes
to the inhibitory effect of NAc input activation. Pause duration
of VP neurons in response to NAc stimulation was significantly
reduced by the application of NK-1 receptor antagonists,
suggesting that SP released from these NAc afferents contribute
to the inhibitory effect of NAc afferent activation, via activation
of NK-1 receptors. This contradicts previous research showing
that SP increases the firing rate of VP neurons and SP
antagonists block increases in firing rate seen in response
to NAc stimulation (Mitrovic and Napier, 1998). However
the research of Mitrovic and Napier (1998) was carried out
in vivo, therefore it plausible that the discrepancy results
from the fact that in the intact brain the VP receives several
other external inputs that are silent in the brain slices and
could be modulated presynaptically by SP. Despite our data
showing NK-1 receptor antagonists reduced the duration of
the inhibition, they were not found to have any significant
effect on the baseline firing frequency or the coefficient of
variation of the VP neurons, suggesting that there is little
endogenous activation of these receptors in the VP in the absence
of stimulation. Chen et al.’s (2001) findings suggest that the
majority of NK-1 receptors found in the VP are localized to
cholinergic neurons. These cells could be involved in the effects
reported here. Alternatively, SP may have caused presynaptic
facilitation of GABA release from NAc fibers, thus prolonging
the GABA-induced pauses. Further experiments should be
aimed at testing this intriguing hypothesis. Furthermore, it
could be that SP also affects other tachykinin receptors
in the VP, as NK-3 receptors are known to be found in
the VP (Maeno et al., 1993; Shughrue et al., 1996) and
this alters the effect seen as they were not blocked in the
current study. Future research could target these receptors
or repeat the current work with the application of NK-3
receptor antagonists.
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Implications
In the current study, I have shown a novel method for
investigation of the basal ganglia connections, which can be used
to collect large amounts of data in relatively short periods, and
also provides the ability to stimulate regions of interest and
measure the effects in other afferent regions, providing insights
into the modulatory connections and circuitry of brain regions.
I also provide evidence to show that NK-1 receptors modulate
the inhibition in tonic firing as a result of NAc stimulation,
which provides an intriguing mechanism, that could contribute
to our understanding of how SP application has reinforcing
effects when applied to the VP (Nikolaus et al., 1999). I tentatively
suggest that this may be due to its facilitatory effect on inhibition
produced by the NAc afferents of the VP, and may modulate
reinforcement related signals between the NAc and VP, by
increasing the duration of inhibition exerted by these inputs
on the VP.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the author, without undue reservation.
ETHICS STATEMENT
The animal study was reviewed and approved by University of
Sheffield ethical review and licensing committee.
AUTHOR CONTRIBUTIONS
MCdesigned and carried out experiments, analyzed the data, and
wrote the manuscript.
FUNDING
This study was funded by the Medical Research Council through
Grant MR/K022512/1 (PI: EB).
ACKNOWLEDGMENTS
The content of this manuscript has been published in Chapter
5 as part of the thesis of Clark (2018).
REFERENCES
Bengtson, C. P., Lee, D. J., and Osborne, P. B. (2004). Opposing
electrophysiological actions of 5-HT on noncholinergic and cholinergic
neurons in the rat ventral pallidum in vitro. J. Neurophysiol. 92, 433–443.
doi: 10.1152/jn.00543.2003
Beurrier, C., Ben-Ari, Y., and Hammond, C. (2006). Preservation of the direct
and indirect pathways in an in vitro preparation of the mouse basal ganglia.
Neuroscience 140, 77–86. doi: 10.1016/j.neuroscience.2006.02.029
Bolam, J. P., Ingham, C. A., Izzo, P. N., Levey, A. I., Rye, D. B., Smith, A. D., et al.
(1986). Substance P-containing terminals in synaptic contact with cholinergic
neurons in the neostriatum and basal forebrain: a double immunocytochemical
study in the rat. Brain Res. 397, 279–289. doi: 10.1016/0006-8993(86)90629-3
Chen, L. W., Wei, L. C., Liu, H. L., Qiu, Y., and Chan, Y. S. (2001). Cholinergic
neurons expressing substance P receptor (NK1) in the basal forebrain of
the rat: a double immunocytochemical study. Brain Res. 904, 161–166.
doi: 10.1016/s0006-8993(01)02460-x
Chrobak, J. J., and Napier, T. C. (1993). Opioid and GABA modulation of
accumbens-evoked ventral pallidal activity. J. Neural Transm. Gen. Sect. 93,
123–143. doi: 10.1007/BF01245342
Churchill, L., and Kalivas, P. W. (1994). A topographically organized gamma-
aminobutyric acid projection from the ventral pallidum to the nucleus
accumbens in the rat. J. Comp. Neurol. 345, 579–595. doi: 10.1002/cne.
903450408
Churchill, L., Dilts, R. P., and Kalivas, P. W. (1990). Changes in γ-aminobutyric
acid, µ-opioid and neurotensin receptors in the accumbens-pallidal projection
after discrete quinolinic acid lesions in the nucleus accumbens. Brain Res. 511,
41–54. doi: 10.1016/0006-8993(90)90223-x
Clark, M. (2018). An electrophysiological investigation of the extrinsic modulation
of ventral pallidum neurons by dopamine and serotonin. The University of
Sheffield. Thesis. Available online at: http://etheses.whiterose.ac.uk/22438/.
Accessed September 25, 2019.
Clark, M., and Bracci, E. (2018). Dichotomous dopaminergic control of ventral
pallidum neurons. Front. Cell Neurosci. 12:260. doi: 10.3389/fncel.2018.00260
Creed, M., Niels, N. R., Chandra, R., Lobo, M. K., and Lüscher, C. (2016).
Convergence of reinforcing and anhedonic cocaine effects in the ventral
pallidum. Neuron 92, 214–226. doi: 10.1016/j.neuron.2016.09.001
Duncan, G. E., Breese, G. R., Criswell, H. E., McCown, T. J., Herbert, J. S.,
Devaud, L. L., et al (1995). Distribution of [3H]zolpidem binding sites
in relation to messenger RNA encoding the alpha 1, beta 2 and gamma
2 subunits of GABAA receptors in rat brain. Neuroscience 64, 1113–1128.
doi: 10.1016/0306-4522(94)00433-6
Goetz, T., Arslan, A., Wisden, W., and Wulff, P. (2007). GABAA receptors:
structure and function in the basal ganglia. Prog. Brain Res. 160, 21–41.
doi: 10.1016/S0079-6123(06)60003-4
Grove, E. A., Domesick, V. B., and Nauta, W. J. H. (1986). Light microscopic
evidence of striatal input to intrapallidal neurons of cholinergic cell group
Ch4 in the rat: a study employing the anterograde tracerPhaseolus vulgaris
leucoagglutinin (PHA-L). Brain Res. 367, 379–384. doi: 10.1016/0006-
8993(86)91623-9
Haber, S. N., Groenewegen, H. J., Grove, E. A., and Nauta, W. J. (1985).
Efferent connections of the ventral pallidum: evidence of a dual striato
pallidofugal pathway. J. Comp. Neurol. 235, 322–335. doi: 10.1002/cne.9023
50304
Henderson, Z. (1995). Expression of GABAA receptor subunit messenger RNA in
non-cholinergic neurons of the rat basal forebrain.Neuroscience 65, 1077–1086.
doi: 10.1016/0306-4522(94)00542-d
Kitamura, M., Ikeda, H., Koshikawa, N., and Cools, A. R. (2001). GABA A
agents injected into the ventral pallidum differentially affect dopaminergic
pivoting and cholinergic circling elicited from the shell of the nucleus
accumbens. Neuroscience 104, 117–127. doi: 10.1016/s0306-4522(01)
00053-7
Kupchik, Y. M., and Kalivas, P. W. (2016). The direct and indirect pathways of
the nucleus accumbens are not what you think. Neuropsychopharmacology 42,
369–370. doi: 10.1038/npp.2016.160
Lahti, R. A., Mickelson, M. M., Jodelis, K. S., and McCall, J. M. (1989).
Comparative neuroanatomical distribution of the κ and µ opioid receptors in
guinea pig brain sections. Eur. J. Pharmacol. 166, 563–566. doi: 10.1016/0014-
2999(89)90377-4
Lu, X. Y., Behnam Ghasemzadeh, M., and Kalivas, P. W. (1997). Expression of
D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the
neurons projecting from the nucleus accumbens. Neuroscience 82, 767–780.
doi: 10.1016/s0306-4522(97)00327-8
Maeno, H., Kiyama, H., and Tohyama, M. (1993). Distribution of the
substance P receptor (NK-1 receptor) in the central nervous system.
Brain Res. Mol. Brain Res. 18, 43–58. doi: 10.1016/0169-328x(93)
90172-l
Mitrovic, I., and Napier, T. C. (1995). Electrophysiological demonstration of µ, δ
and κ opioid receptors in the ventral pallidum. J. Pharmacol. Exp. Ther. 272,
1260–1270.
Frontiers in Cellular Neuroscience | www.frontiersin.org 12 November 2020 | Volume 14 | Article 599920
Clark NAc Afferents Effect VP neurons
Mitrovic, I., and Napier, T. C. (1998). Substance P attenuates and DAMGO
potentiates amygdala glutamatergic neurotransmission within the ventral
pallidum. Brain Res. 792, 193–206. doi: 10.1016/s0006-8993(98)00130-9
Mogenson, G. J., Swanson, L. W., and Wu, M. (1983). Neural projections from
nucleus accumbens to globus pallidus, substantia innominata and lateral
preoptic-lateral hypothalamic area: an anatomical and electrophysiological
investigation in the rat. J. Neurosci. 3, 189–202. doi: 10.1523/JNEUROSCI.03-
01-00189.1983
Napier, T. C., andMitrovic, I. (1999). Opioidmodulation of ventral pallidal inputs.
Ann. N. Y. Acad. Sci. 877, 176–201. doi: 10.1111/j.1749-6632.1999.tb09268.x
Napier, T. C., Chrobak, J. J., and Yew, J. (1992). Systemic and microiontophoretic
administration of morphine differentially effect ventral pallidum/substantia
innominata neuronal activity. Synapse 12, 214–219. doi: 10.1002/syn.
890120306
Napier, T. C., Mitrovic, I., Churchill, L., Klitenick, M. A., Lu, X. Y., and
Kalivas, P. W. (1995). Substance P in the ventral pallidum: projection from the
ventral striatum and electrophysiological and behavioral cinsequences
of pallidal substance P. Neuroscience 69, 59–70. doi: 10.1016/0306-
4522(95)00218-8
Nikolaus, S., Huston, J. P., and Hasenöhrl, R. U. (1999). Reinforcing effects
of neurokinin substance P in the ventral pallidum: mediation by the
tachykinin NK1 receptor. Eur. J. Pharmacol. 370, 93–99. doi: 10.1016/s0014-
2999(99)00105-3
Ogura, M., and Kita, H. (2000). Dynorphin exerts both postsynaptic and
presynaptic effects in the globus pallidus of the rat. J. Neurophysiol. 83,
3366–3376. doi: 10.1152/jn.2000.83.6.3366
Olive, M., Anton, B., Micevych, P., Evans, C., and Maidment, N. (1997).
Presynaptic versus postsynaptic localization of mu and delta opioid receptors
in dorsal and ventral striatopallidal pathways. J. Neurosci. 17, 7471–7479.
doi: 10.1523/JNEUROSCI.17-19-07471.1997
Pettersen, K. H., and Einevoll, G. T. (2008). Amplitude variability and
extracellular low-pass filtering of neuronal spikes. Biophys. J. 94, 784–802.
doi: 10.1529/biophysj.107.111179
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., and Sperk, G. (2000).
GABAA receptors: immunocytochemical distribution of 13 subunits in the
adult rat brain. Neuroscience 101, 815–850. doi: 10.1016/s0306-4522(00)
00442-5
Purves, D. (2001). Neuroscience. 4th Edn. Sunderland, MA: Sinauer Associates.
Reiner, A., and Anderson, K. D. (1990). The patterns of neurotransmitter and
neuropeptide co-occurrence among striatal projection neurons: conclusions
based on recent findings. Brain Res. Rev. 15, 251–265. doi: 10.1016/0165-
0173(90)90003-7
Root, D. H., Melendez, R. I., Zaborszky, L., and Napier, T. C. (2015). The
ventral pallidum: subregion-specific functional anatomy and roles in motivated
behaviors. Prog. Neurobiol. 130, 29–70. doi: 10.1016/j.pneurobio.2015.
03.005
Shughrue, P. J., Lane, M. V., and Merchenthaler, I. (1996). In situ hybridization
analysis of the distribution of neurokinin- 3 mRNA in the rat central
nervous system. J. Comp. Neurol. 372, 395–414. doi: 10.1002/(SICI)1096-
9861(19960826)372:3<395::AID-CNE5>3.0.CO;2-Y
Smith, K. S., and Berridge, K. C. (2005). The ventral pallidum and hedonic
reward: neurochemical maps of sucrose ‘‘liking’’ and food intake. J. Neurosci.
25, 8637–8649. doi: 10.1523/JNEUROSCI.1902-05.2005
Wagenaar, D. A., Madhavan, R., Pine, J., and Potter, S. M. (2005).
Controlling bursting in cortical cultures with closed- loop multi- electrode
stimulation. J. Neurosci. 25, 680–688. doi: 10.1523/JNEUROSCI.4209-
04.2005
Wagenaar, D. A., Pine, J., and Potter, S. M. (2004). Effective parameters for
stimulation of dissociated cultures using multi-electrode arrays. J. Neurosci.
Methods 138, 27–37. doi: 10.1016/j.jneumeth.2004.03.005
Walaas, I., and Fonnum, F. (1979). The distribution and origin of glutamate
decarboxylase and choline acetyltransferase in ventral pallidum and other
basal forebrain regions. Brain Res. 177, 325–336. doi: 10.1016/0006-8993(79)
90783-2
Wang, L., Shen, M., Yu, Y., Tao, Y., Zheng, P., Wang, F., et al. (2014).
Optogenetic activation of GABAergic neurons in the nucleus accumbens
decreases the activity of the ventral pallidum and the expression of cocaine-
context-associated memory. Int. J. Neuropsychopharmacol. 17, 753–763.
doi: 10.1017/S1461145713001570
Yang, C. R., and Mogenson, G. J. (1985). An electrophysiological study of
the neural projections from the hippocampus to the ventral pallidum and
the subpallidal areas by way of the nucleus accumbens. Neuroscience 15,
1015–1024. doi: 10.1523/JNEUROSCI.18-13-05095.1998
Zaborszky, L. (1989). Afferent connections of the forebrain cholinergic projection
neurons, with special reference to monoaminergic and peptidergic fibers. EXS
57, 12–32. doi: 10.1007/978-3-0348-9138-7_2
Zaborszky, L., and Cullinan, W. (1992). Projections from the nucleus accumbens
to cholinergic neurons of the ventral pallidum: a correlated light and electron
microscopic double immunolabelling study in rat. Brain Res. 570, 92–101.
doi: 10.1016/0006-8993(92)90568-t
Zaborszky, L., Heimer, L., Eckenstein, F., and Leranth, C. (1986). GABAergic input
to cholinergic forebrain neurons: an ultrastructural study using retrograde
tracing of HRP and double immunolabeling. J. Comp. Neurol. 250, 282–295.
doi: 10.1002/cne.902500303
Zilles, K., Werner, L., Qu, M., Schleicher, A., and Gross, G. (1991).
Quantitative autoradiography of 11 different transmitter binding sites
in the basal forebrain region of the rat–evidence of heterogeneity in
distribution patterns. Neuroscience 42, 473–481. doi: 10.1016/0306-4522(91)
90390-a
Conflict of Interest: The author declares that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Clark. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 13 November 2020 | Volume 14 | Article 599920
